New Republic Capital’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$442K Sell
934
-298
-24% -$150K 0.15% 122
2025
Q4
$575K Buy
1,232
+196
+19% +$91K 0.15% 120
2025
Q3
$442K Sell
1,036
-336
-24% -$130K 0.14% 100
2025
Q2
$526K Buy
1,372
+42
+3% +$15.1K 0.19% 78
2025
Q1
$460K Sell
1,330
-4
-0.3% -$1.29K 0.2% 84
2024
Q4
$400K Sell
1,334
-676
-34% -$236K 0.26% 92
2024
Q3
$817K Sell
2,010
-6
-0.3% -$2.2K 0.47% 45
2024
Q2
$648K Sell
2,016
-31
-2% -$10.1K 0.33% 59
2024
Q1
$684K Sell
2,047
-72
-3% -$22K 0.43% 51
2023
Q4
$574K Buy
2,119
+23
+1% +$5.68K 0.41% 56
2023
Q3
$516K Sell
2,096
-392
-16% -$107K 0.42% 56
2023
Q2
$755K Buy
2,488
+24
+1% +$6.67K 0.52% 38
2023
Q1
$650K Sell
2,464
-74
-3% -$18.8K 0.49% 40
2022
Q4
$609K Buy
+2,538
New +$568K 0.48% 39

Other funds holding HCA

New Republic Capital's HCA Position: Q1 2026 in Review

New Republic Capital reduced its HCA Healthcare (HCA) stake by 24% in Q1 2026, selling an estimated $150K and leaving 934 shares worth $442K. The position accounts for 0.15% of the portfolio, ranked #122.

New Republic Capital first reported a position in HCA in Q4 2022 and has held it in 14 quarters since. The position peaked at $817K in Q3 2024. 1,414 funds tracked by Wall St. Rank hold HCA as of Q1 2026.

  • New Republic Capital held 934 shares of HCA Healthcare worth $442K as of Q1 2026.
  • New Republic Capital sold 298 HCA Healthcare shares in Q1 2026, an estimated $150K.
  • HCA Healthcare made up 0.15% of New Republic Capital's portfolio in Q1 2026, its #122 holding.
  • New Republic Capital first reported a position in HCA Healthcare in Q4 2022 and has held it in 14 quarters since.
  • New Republic Capital's HCA Healthcare position peaked at $817K in Q3 2024.
  • 1,414 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2026.

Based on New Republic Capital's 13F filing for Q1 2026, filed 1 May 2026.